InvestSMART

Alphinity Global Equity Fund (Managed Fund) (ASX: XALG) - Announcements

- Current share price for XALG : $10.670

Alphinity Global Equity Fund (Managed Fund) (XALG) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Alphinity Global Equity Fund (Managed Fund) (XALG) is an exchange traded fund which is managed by Alphinity.

Latest company announcements for Alphinity Global Equity Fund (Managed Fund) (XALG)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$321 Pause in Trade 1 Jul 2025 10:10AM $11.510 $10.670 fallen by 7.30%
$321 Estimated Annual Distribution 26 Jun 2025 2:24PM $11.500 $10.670 fallen by 7.22%
$321 Indicative 30 June 2025 Distribution Calendar 20 Jun 2025 2:37PM $11.270 $10.670 fallen by 5.32%
$321 Lifting of Trading Halt 17 Jun 2025 12:51PM $11.370 $10.670 fallen by 6.16%
$321 Trading Halt - XALG 17 Jun 2025 11:55AM $11.370 $10.670 fallen by 6.16%
$321 Pause in Trade 17 Jun 2025 11:13AM $11.370 $10.670 fallen by 6.16%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 5 Jun 2025 3:30PM $11.470 $10.670 fallen by 6.97%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 5 May 2025 11:20AM $11.060 $10.670 fallen by 3.53%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 3 Apr 2025 2:06PM $10.910 $10.670 fallen by 2.20%
$321 Quarterly disclosure of portfolio holdings - Jan 2025 1 Apr 2025 4:37PM $11.110 $10.670 fallen by 3.96%
$321 Half Year Accounts 6 Mar 2025 10:49AM $11.740 $10.670 fallen by 9.11%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 5 Mar 2025 2:38PM $11.650 $10.670 fallen by 8.41%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 4 Feb 2025 5:43PM $12.380 $10.670 fallen by 13.81%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 6 Jan 2025 2:43PM $12.130 $10.670 fallen by 12.04%
$321 Quarterly disclosure of portfolio holdings - Oct 2024 2 Jan 2025 10:08AM $12.100 $10.670 fallen by 11.82%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 9 Dec 2024 2:08PM $12.350 $10.670 fallen by 13.60%
$321 XALG - Naming Convention Announcement & updated PDS 21 Nov 2024 10:00AM $11.720 $10.670 fallen by 8.96%
$321 Monthly Redemptions, Units on issue & OTC Exposure 5 Nov 2024 2:18PM $11.250 $10.670 fallen by 5.16%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 4 Oct 2024 1:14PM $10.730 $10.670 fallen by 0.56%
$321 Quarterly disclosure of portfolio holdings - July 2024 3 Oct 2024 11:23AM $10.660 $10.670 risen by 0.09%
$321 FY2024 Annual Financial Report 25 Sep 2024 3:19PM $10.790 $10.670 fallen by 1.11%
$321 Monthly Redemptions, Units on issue & Derivative Exposure 5 Sep 2024 9:09AM $10.960 $10.670 fallen by 2.65%
$321 Monthly Redemptions, Units on issue & OTC Exposure 5 Aug 2024 6:53PM $10.570 $10.670 risen by 0.95%
$321 Monthly Redemptions, Units on issue & OTC Exposure 5 Jul 2024 5:25PM n/a $10.670 n/a
$321 Final Annual Distribution 3 Jul 2024 1:11PM n/a $10.670 n/a

26 - 50 of 54 results

Page 2 of 3

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.